-
Mashup Score: 2CAR T-cell Therapy in CLL (chronic lymphocytic leukemia): Navigating the Landscape and Looking Ahead with Catherine Coombs, MD - 12 day(s) ago
Introduction During a comprehensive presentation by Dr. Catherine Coombs at UC Irvine, insights into the unique challenges and opportunities of using CAR T-c
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani - 13 day(s) ago
Introduction At a recent conference, Dr. Anjali Advani of the Cleveland Clinic discussed the transformative role of Chimeric Antigen Receptor T-cell (CAR-T)
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Introduction During the CAR-T & Bispecifics Conference, Dr. Brian Sworder, MD, from UCI Irvine, shared compelling insights on the utility of circulating
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Nitin Jain, MD Challenging case involving advanced B-cell lymphoblastic leukemia (BLL) from the CAR-T and Bispecifics Conference [2024] - 13 day(s) ago
Introduction During the recent CAR-T & Bispecifics conference, Dr. Nitin Jain, MD, from MD Anderson Cancer Center in Houston, Texas, presented a challeng
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Enhertu DESTINY-Breast06 Phase III Study the Impact on HR-Positive, HER2-Low Metastatic Breast Cancer Revealed - 13 day(s) ago
Introduction The recent findings from the DESTINY-Breast06 Phase III trial signify a potential shift in the treatment landscape for HR-positive, HER2-low met
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0FDA Approves New Bladder Cancer Therapy: A Look at Anktiva Nogapendekin Alfa Inbakicept-pmln - 13 day(s) ago
Introduction The US Food and Drug Administration (FDA) recently approved nogapendekin alfa inbakicept-pmln (Anktiva), used in conjunction with bacillus Calme
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Overview of SYNC-T Technology from Syncromune in Prostate Cancer Treatment - Charles Link, MD - 24 day(s) ago
Dive into the SYNC-T technology by Syncromune® Inc. and its groundbreaking approach to hormone-refractory prostate cancer. Learn how it stimulates an immune response within the tumor microenvironment and adjacent lymph nodes.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 12Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies - Elias Jabbour, MD - 24 day(s) ago
Introduction to Emerging Therapies in ALL Management … Dr. Elias Jabbour shared recent developments in the treatment of acute lymphoblastic leukemia (ALL) during a recent medical conference. His presentation focused on the evolving landscape of ALL therapy, particularly emphasizing the growing importance of targeted therapies including bispecific antibodies, antibody-drug conjugates (ADCs), and tyrosine kinase inhibitors
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Scott Kopetz, MD - KRYSTAL-1: Adagrasib-Cetuximab for KRASG12C CRC - 1 month(s) ago
Dr. Scott Kopetz discussed the KRYSTAL-1 study at AACR, presenting promising results of combining adagrasib and cetuximab to target KRASG12C mutated colorectal cancer, reporting a 34% response rate, with progression-free survival of 6.9 months and overall survival of 15.9 months in heavily pretreated patients.
Source: videos.oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Ajay Goel, PhD - Exosome Biopsy Detects Pancreatic Cancer - 1 month(s) ago
Dr. Ajay Goel presented a novel blood-based liquid biopsy for early detection of pancreatic cancer, utilizing a combination of microRNAs and exosomes to achieve a diagnostic accuracy of 92-97%. This approach, unique for its use of both cell-free and exosomal microRNAs, was validated across multiple international cohorts.
Source: videos.oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
VIDEO: CAR T-cell Therapy in CLL (chronic lymphocytic leukemia): Navigating the Landscape and Looking Ahead with Catherine Coombs, MD https://t.co/BZFpPkuMR2 @UCIrvineHealth @_MDEducation @Ryan_fitzpatric https://t.co/2asWxiIg41